The role of the IL23/IL17 pathway in inflammatory bowel disease

The role of the IL23/IL17 pathway in inflammatory bowel disease

<p>The aetiology of IBD is unknown, but available evidence suggests that an aberrant immune response towards the commensal microbial flora is responsible for intestinal inflammation in genetically susceptible individuals. Studies from animal models of intestinal inflammation have greatly advan...

Bibliografski detalji
Glavni autor:	Geremia, A
Daljnji autori:	Powrie, F
Format:	Disertacija
Jezik:	English
Izdano:	2011
Teme:	Gastroenterology Immunology Medical Sciences

Slični predmeti

The role of IL-1beta in intestinal inflammation
od: Coccia, M, i dr.
Izdano: (2011)

Studies of intestinal inflammation: the roles of IL-23R, gamma-delta T-cells and IL-21i
od: Shale, M
Izdano: (2013)

The role of IL-18 in intestinal immune regulation
od: Harrison, O, i dr.
Izdano: (2013)

The role of IL-18 in intestinal immune regulation
od: Harrison, OJ
Izdano: (2013)

Investigation of the signalling and function of NOD2
od: Brain, A
Izdano: (2013)

Genetic studies in ulcerative colitis
od: Bryant, RV
Izdano: (2015)

Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemic
od: Alex Barnes, i dr.
Izdano: (2021-05-01)

Selective IgA2 deficiency in a patient with small intestinal Crohn’s disease
od: Pablo Canales-Herrerias, i dr.
Izdano: (2023-06-01)

The function of NOD2 in antigen presenting cells
od: Allan, P
Izdano: (2012)

Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease
od: Patricia Kaazan, i dr.
Izdano: (2021-09-01)

Innate immune pathways controlling IL-1beta production and adjuvant-induced T helper 17 cell differentiation
od: Shenderov, K
Izdano: (2011)

Implications of HCV genotype 3 specific immunity on cross-reactive vaccine design
od: von Delft, A, i dr.
Izdano: (2014)

Microbial signals, MyD88, and lymphotoxin drive TNF-independent intestinal epithelial tissue damage
od: Iulia Rusu, i dr.
Izdano: (2022-03-01)

The minichromosome maintenance complex drives esophageal basal zone hyperplasia
od: Mark Rochman, i dr.
Izdano: (2023-09-01)

Cystathionine γ-lyase exacerbates Helicobacter pylori immunopathogenesis by promoting macrophage metabolic remodeling and activation
od: Yvonne L. Latour, i dr.
Izdano: (2022-06-01)

Intestinal epithelial HDAC3 and MHC class II coordinate microbiota-specific immunity
od: Emily M. Eshleman, i dr.
Izdano: (2023-02-01)

TSLP/dendritic cell axis promotes CD4+ T cell tolerance to the gut microbiome
od: Jonathan L. Messerschmidt, i dr.
Izdano: (2023-07-01)

AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas
od: Pradipta Ghosh, i dr.
Izdano: (2022-09-01)

SMAD4 TGF-β–independent function preconditions naive CD8+ T cells to prevent severe chronic intestinal inflammation
od: Ramdane Igalouzene, i dr.
Izdano: (2022-04-01)

Use of genome wide expression profiles in analysis of T cell dysfunction in Hepatitis C virus infection
od: Gupta, P
Izdano: (2014)

Investigating checkpoint inhibitor-induced gastrointestinal disease: comparisons with idiopathic ulcerative colitis and health
od: Gupta, T
Izdano: (2022)

Function, phenotype and development of human CD161+CD8 T cells
od: Walker, LJ
Izdano: (2012)

Single cell atlas of human gastric muscle immune cells and macrophage-driven changes in idiopathic gastroparesis
od: Lakshmikanth L. Chikkamenahalli, i dr.
Izdano: (2024-03-01)

Gut-microbiota-based ensemble model predicts prognosis of pediatric inflammatory bowel disease
od: Sung Min Ha, i dr.
Izdano: (2024-12-01)

Prolonged dysbiosis and altered immunity under nutritional intervention in a physiological mouse model of severe acute malnutrition
od: Fanny Hidalgo-Villeda, i dr.
Izdano: (2023-06-01)

Forward genetic and cellular studies of immune regulation: the roles of Carma1, Interleukin-10 and Gimap5
od: Barnes, MJ
Izdano: (2010)

Role of the IL23/IL17 Pathway in Crohn’s Disease
od: Heike Schmitt, i dr.
Izdano: (2021-03-01)

Contrast‐enhanced ultrasonography in dogs with inflammatory bowel disease
od: Nikolina Linta, i dr.
Izdano: (2021-09-01)

Achieving Treatment Goals in Inflammatory Bowel Disease: The Role of Gut-Selective Therapy
od: Gert Van Assche, i dr.
Izdano: (2015-12-01)

Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis
od: Leo R. Fitzpatrick
Izdano: (2012-01-01)

IL-23 tunes inflammatory functions of human mucosal-associated invariant T cells
od: Laetitia Camard, i dr.
Izdano: (2025-02-01)

Pirfenidone increases IL-10 and improves acute pancreatitis in multiple clinically relevant murine models
od: Ejas Palathingal Bava, i dr.
Izdano: (2022-01-01)

Bacterially Derived Tryptamine Increases Mucus Release by Activating a Host Receptor in a Mouse Model of Inflammatory Bowel Disease
od: Yogesh Bhattarai, i dr.
Izdano: (2020-12-01)

Stem cell and niche regulation in human short bowel syndrome
od: Vered A. Gazit, i dr.
Izdano: (2020-12-01)

Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
od: Claudia Schinocca, i dr.
Izdano: (2021-02-01)

Connective tissue changes in patients with rectal prolapse
od: Smyth, EAE
Izdano: (2012)

Identification of the cellular and molecular mechanisms of IL-23 driven intestinal inflammation
od: Schiering, C
Izdano: (2013)

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.
od: Geremia, A, i dr.
Izdano: (2011)

The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
od: Taoming Liu, i dr.
Izdano: (2020-11-01)

Osteopontin regulation of MerTK+ macrophages promotes Crohn’s disease intestinal fibrosis
od: Juanhan Liu, i dr.
Izdano: (2024-07-01)